Report - XENERA™-1: A phase II trial of xentuzumab in combination with … · 2021. 1. 28. · Peter Schmid1*, Hope S. Rugo2, Javier Cortés3, Dennis Chin-Lun Huang4, Kate Crossley5, Dan

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form